- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
San Clemente Today
By the People, for the People
Comparing Vyome (HIND) and Its Competitors
Vyome is one of 28 publicly-traded companies in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, but how does it compare to its peers?
Published on Mar. 4, 2026
Got story updates? Submit your updates here. ›
This article compares Vyome (NASDAQ:HIND), a medical device company, to its peers in the 'Surgical, Medical, And Dental Instruments And Supplies' industry. It looks at factors like net margins, return on equity, return on assets, analyst ratings, revenue, earnings per share, and valuation to determine how Vyome stacks up against the competition.
Why it matters
Investors and industry analysts are interested in understanding how Vyome performs relative to its competitors in order to assess the company's overall competitiveness and investment potential within the medical device sector.
The details
The analysis finds that Vyome has a lower stock price volatility compared to its peers, as measured by beta. It also has stronger net margins, return on equity, and return on assets than its competitors. Vyome has a more favorable consensus rating from analysts and a higher potential upside compared to the industry average. While Vyome's peers have higher revenue, Vyome has higher earnings per share and a lower price-to-earnings ratio, indicating it is more affordable than other companies in the industry.
- The article was published on 2026-03-04 07:56:44.
The players
Vyome
A publicly-traded company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry.
ReShape Lifesciences Inc.
A medical device company that provides products and services to manage and treat obesity and metabolic diseases.
The takeaway
The analysis suggests that Vyome is a relatively strong performer in the medical device industry, with favorable financial metrics, analyst ratings, and valuation compared to its peers. This information could be useful for investors considering Vyome as a potential investment opportunity.
